SPY431.24-2.14 -0.49%
DIA341.55+0.09 0.03%
IXIC13,352.78-189.34 -1.40%

BRIEF-Salarius Pharmaceuticals Achieves Dosing Milestone In Ongoing Phase 1/2 Sarcoma Trial

reuters.com · 12/29/2021 08:03
BRIEF-Salarius Pharmaceuticals Achieves Dosing Milestone In Ongoing Phase 1/2 Sarcoma Trial

- Salarius Pharmaceuticals Inc SLRX:

  • SALARIUS PHARMACEUTICALS ACHIEVES DOSING MILESTONE IN ONGOING PHASE 1/2 SARCOMA TRIAL

Source text for Eikon: ID:nGNX7wShck

Further company coverage: SLRX


((Reuters.Briefs@thomsonreuters.com;))